from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1120c/-

LFCtreatmentdescriptionclass of inhibitor

0.635

Amikacinug/mL Amikacintranslation

0.952

Cap5-10ug/mL Capreomycintranslation

1.028

Rox10-50 ug/mL Roxithromycintranslation

0.485

SM2-5 ug/mL Streptomycintranslation

0.424

Tet5-10 ug/mL Tetracyclinetranslation

0.761

Rif0.2-5ug/mL Rifampicintranscription

0.057

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.087

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.841

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.416

CPZ10-50 ug/mL Chlorpromazinerespiration

0.084

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.371

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.216

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.717

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.543

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.734

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.529

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.457

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.618

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.596

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.409

KCN5-20 ug/mL Potassium cyaniderespiration

-0.713

NaN30.2-2 mM Sodium aziderespiration

-0.799

Nigericin50 uM Nigericinrespiration

0.074

TRC10-150 ug/mL Triclosanrespiration

1.704

TRZ10-25 ug/mL Thioridazinerespiration

-0.522

Valinomycin0.5-10 uM Valinomycinrespiration

-0.320

ZnSO42 mM ZnSO4respiration

-0.596

menadione6-10 ug/mL Menadionerespiration

-0.063

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.516

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.141

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.628

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.469

NRP_1Non-replicating persistence stage 1dosRassociated

0.029

Amp0.2mg/mL AmpicillincellWall

-0.441

Cephalexin20-100 ug/mL CephalexincellWall

-0.350

Cerulenin0.32-5 ug/mL CerulenincellWall

0.529

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.276

EMB10-20 ug/mL EthambutolcellWall

-0.699

Eta12-40 ug/mL EthionamidecellWall

-0.666

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.647

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.835

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.051

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.218

BZA0.12 mg/mL BenzamidearomaticAmides

0.299

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.742

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.914

H2O24 mM hydrogen peroxideDNAdamaging

0.247

Levo10 ug/mL LevofloxacinDNAdamaging

0.111

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.310

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.048

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.294

UVUV-irradiationDNAdamaging

1.052

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.518

Antimycin12.5-50 ug/mL Antimycin A?

-0.286

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.067

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.367

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.997

PA8240.2-2 ug/mL PA-824?

-0.246

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.239

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.739

Verapamil50 uM Verapamil?

0.017

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.177

methoxatin10-20 ug/mL Methoxatin?